ORIGINAL RESEARCH
Published on 17 Jul 2025
Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
doi 10.3389/fendo.2025.1496671
- 503 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
8,771
Total downloads
30k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Jun 2025
Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease
doi 10.3389/fendo.2025.1500242
- 1,115 views
CASE REPORT
Published on 26 May 2025
Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
doi 10.3389/fendo.2025.1501984
- 1,506 views
ORIGINAL RESEARCH
Published on 17 Feb 2025
Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children
doi 10.3389/fendo.2025.1505050
- 984 views
ORIGINAL RESEARCH
Published on 14 Jan 2025
The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
doi 10.3389/fendo.2024.1499735
- 1,410 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
doi 10.3389/fendo.2024.1506953
- 882 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Dec 2024
Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study
doi 10.3389/fendo.2024.1426103
- 2,121 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe
doi 10.3389/fmed.2024.1383112
- 1,414 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Sep 2024
Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores
doi 10.3389/fmed.2024.1431935
- 3,006 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools
doi 10.3389/fmed.2024.1425145
- 1,175 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2024
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study
doi 10.3389/fendo.2024.1451383
- 1,246 views
- 12 citations
REVIEW
Published on 23 May 2024
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
doi 10.3389/fendo.2024.1411706
- 3,063 views
- 5 citations
